Disqus Shortname

Breaking News

ICMR Will Get Royalty of 5% from Sale of Bharat Biotech's Covaxin. Here's Why It's Raising Eyebrows

The intellectual property governing the use of Covaxin, jointly developed by Bharat Biotech and the ICMR, was “shared” and that is why it would receive royalty payments.

from Top India News- News18.com https://ift.tt/3fo6oP0
via IFTTT

ليست هناك تعليقات